ELISABETH STEIN

H.R. 1844/S. 878 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts.(Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 6-30-13, relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts. H.R. 1910 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. General lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. H.R.982 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. General lobbying with regard to the regulation of compounding pharmacies and preservation of state-based causes of action. General lobbying with regard to the ability of consumers and injured parties to bring class actions. General lobbying with regard to the ability of injured consumers to bring causes of action against manufacturers and sellers of defective products. (Location Privacy Protection Act of 2012); draft legislation not formally introduced as of 6-30-2013; to address voluntary location tracking of electronic communications devices. General lobbying with regard to alternative litigation funding. General lobbying with regard to notice pleading. in civil actions. General lobbying with regard to limitations on the ability to bring class actions involving the securities industry. S. 954 (Agriculture Reform, Food, and Jobs Act of 2013); specific interest in proposed amendment (not formally offered) relating to attorneys fees. S.1009 (Chemical Safety Improvement Act of 2013); to improve the safety of consumers and modernize the Toxic Substances Control Act. H.R. 1773 (AG Act); specific interest in amendments (offered in Committee) relating to requirement that farm employees mediate/arbitration all claims. S. 394 (Metal Theft Prevention Act of 2013); specific interest in proposed amendment (not formally offered) relating to transparency for outside counsel retained by State Attorneys General. General lobbying with regard to the Monsanto Protection Act; to limit judicial review of genetically modified seeds.

Lobbying with regard to medical malpractice reform proposals generally, including issues relating to health courts and practice guidelines for providers.H.R. 2094 (School Access to Emergency Epinephrine Act) specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine H.R. 332 (Equal Access to Justice for Victims of Gun Violence Act); to provide victims of gun violence access to the same civil remedies as are available to those injured through other means. General lobbying with regard to the liability of rental car companies. H.R. 1473 (Standard of Care Protection Act of 2013); to prevent certain Federal health care laws from establishing health care provider standards of care. H.R. 1733 (Good Samaritan Health Professionals Act of 2013); to limit the liability of health care professionals who volunteer to provide health care service in response to a disaster. (Safeguarding Access For Every Medicare Patient Act); draft legislation not formally introduced as of 6-30-13; to address electronic health records.

Lobbying with regard to medical malpractice reform proposals generally.(School Access to Emergency Epinephrine Act) not formally introduced as of 3-31-2013; specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine. H.R. 332 (Equal Access to Justice for Victims of Gun Violence Act); to provide victims of gun violence access to the same civil remedies as are available to those injured through other means. General lobbying with regard to the liability of rental car companies.

Lobbying with regard to medical malpractice reform proposals generally, including issues relating to health courts and practice guidelines for providers.H.R. 2094 (School Access to Emergency Epinephrine Act) specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine H.R. 332 (Equal Access to Justice for Victims of Gun Violence Act); to provide victims of gun violence access to the same civil remedies as are available to those injured through other means. General lobbying with regard to the liability of rental car companies. H.R. 1473 (Standard of Care Protection Act of 2013); to prevent certain Federal health care laws from establishing health care provider standards of care. H.R. 1733 (Good Samaritan Health Professionals Act of 2013); to limit the liability of health care professionals who volunteer to provide health care service in response to a disaster. (Safeguarding Access For Every Medicare Patient Act); draft legislation not formally introduced as of 6-30-13; to address electronic health records.

H.R. 1844/S. 878 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts.(Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 6-30-13, relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts. H.R. 1910 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. General lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. H.R.982 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. General lobbying with regard to the regulation of compounding pharmacies and preservation of state-based causes of action. General lobbying with regard to the ability of consumers and injured parties to bring class actions. General lobbying with regard to the ability of injured consumers to bring causes of action against manufacturers and sellers of defective products. (Location Privacy Protection Act of 2012); draft legislation not formally introduced as of 6-30-2013; to address voluntary location tracking of electronic communications devices. General lobbying with regard to alternative litigation funding. General lobbying with regard to notice pleading. in civil actions. General lobbying with regard to limitations on the ability to bring class actions involving the securities industry. S. 954 (Agriculture Reform, Food, and Jobs Act of 2013); specific interest in proposed amendment (not formally offered) relating to attorneys fees. S.1009 (Chemical Safety Improvement Act of 2013); to improve the safety of consumers and modernize the Toxic Substances Control Act. H.R. 1773 (AG Act); specific interest in amendments (offered in Committee) relating to requirement that farm employees mediate/arbitration all claims. S. 394 (Metal Theft Prevention Act of 2013); specific interest in proposed amendment (not formally offered) relating to transparency for outside counsel retained by State Attorneys General. General lobbying with regard to the Monsanto Protection Act; to limit judicial review of genetically modified seeds.

(Arbitration Fairness Act); not formally introduced as of 3-31-2013, to prohibit mandatory binding arbitration in consumer contracts.(Fairness in Nursing Home Arbitration Act); not formally introduced as of 3-31-13, relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. (Foreign Manufacturers Legal Accountability Act); not formally introduced as of 3-31-2013, to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Gemeral lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. H.R.982 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. General lobbying with regard to the regulation of compounding pharmacies and preservation of state-based causes of action. General lobbying with regard to the ability of consumers and injured parties to bring class actions. General lobbying with regard to the ability of injured consumers to bring causes of action against manufacturers and sellers of defective products. (Location Privacy Protection Act of 2012) not formally introduced as of 3-31-2013; to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General. General lobbying with regard to alternative litigation funding. General lobbying with regard to notice pleading in civil actions. General lobbying with regard to limitations on the ability to bring class actions involving the securities industry.

H.R. 1844/S. 878 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts.(Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 6-30-13, relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts. H.R. 1910 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. General lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. H.R.982 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. General lobbying with regard to the regulation of compounding pharmacies and preservation of state-based causes of action. General lobbying with regard to the ability of consumers and injured parties to bring class actions. General lobbying with regard to the ability of injured consumers to bring causes of action against manufacturers and sellers of defective products. (Location Privacy Protection Act of 2012); draft legislation not formally introduced as of 6-30-2013; to address voluntary location tracking of electronic communications devices. General lobbying with regard to alternative litigation funding. General lobbying with regard to notice pleading. in civil actions. General lobbying with regard to limitations on the ability to bring class actions involving the securities industry. S. 954 (Agriculture Reform, Food, and Jobs Act of 2013); specific interest in proposed amendment (not formally offered) relating to attorneys fees. S.1009 (Chemical Safety Improvement Act of 2013); to improve the safety of consumers and modernize the Toxic Substances Control Act. H.R. 1773 (AG Act); specific interest in amendments (offered in Committee) relating to requirement that farm employees mediate/arbitration all claims. S. 394 (Metal Theft Prevention Act of 2013); specific interest in proposed amendment (not formally offered) relating to transparency for outside counsel retained by State Attorneys General. General lobbying with regard to the Monsanto Protection Act; to limit judicial review of genetically modified seeds.

H.R. 367/S. 15 (Regulations From the Executive in Need of Scrutiny Act of 2013); to amend chapter 8 of title 5, United States Code, to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law.General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. General lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying in support of the nominations of Tim Brooks, Nina Pillard, Robert Wilkins and Patricia Millet. (PETITION Act), not formally introduced as of 6-30-2013; to protect first amendment rights of petition and free speech. General lobbying with regard to the Equal Access to Justice Act.

(Sunshine in Litigation Act of 2011) not formally introduced as of 3-31-2013; relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases.General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. (Draft Legislation; no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. General lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of Caitlin Halligan, Brian Davis, and Patty Schwartz (PETITION Act), not formally introduced as of 3-31-2013; to protect first amendment rights of petition and free speech. H.R. 367/S. 15 (Regulations From the Executive in Need of Scrutiny Act of 2013); to amend chapter 8 of title 5, United States Code, to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. General lobbying with regard to the Feres Doctrine and allowing servicemembers and veterans to bring causes of actions against the U.S. government for alleged torts. General lobbying with regard to the Equal Access to Justice Act.

H.R. 1844/S. 878 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts.(Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 6-30-13, relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts. H.R. 1910 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. General lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. H.R.982 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. General lobbying with regard to the regulation of compounding pharmacies and preservation of state-based causes of action. General lobbying with regard to the ability of consumers and injured parties to bring class actions. General lobbying with regard to the ability of injured consumers to bring causes of action against manufacturers and sellers of defective products. (Location Privacy Protection Act of 2012); draft legislation not formally introduced as of 6-30-2013; to address voluntary location tracking of electronic communications devices. General lobbying with regard to alternative litigation funding. General lobbying with regard to notice pleading. in civil actions. General lobbying with regard to limitations on the ability to bring class actions involving the securities industry. S. 954 (Agriculture Reform, Food, and Jobs Act of 2013); specific interest in proposed amendment (not formally offered) relating to attorneys fees. S.1009 (Chemical Safety Improvement Act of 2013); to improve the safety of consumers and modernize the Toxic Substances Control Act. H.R. 1773 (AG Act); specific interest in amendments (offered in Committee) relating to requirement that farm employees mediate/arbitration all claims. S. 394 (Metal Theft Prevention Act of 2013); specific interest in proposed amendment (not formally offered) relating to transparency for outside counsel retained by State Attorneys General. General lobbying with regard to the Monsanto Protection Act; to limit judicial review of genetically modified seeds.

H.R. 1844/S. 878 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts.(Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 6-30-13, relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts. H.R. 1910 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. General lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. H.R.982 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. General lobbying with regard to the regulation of compounding pharmacies and preservation of state-based causes of action. General lobbying with regard to the ability of consumers and injured parties to bring class actions. General lobbying with regard to the ability of injured consumers to bring causes of action against manufacturers and sellers of defective products. (Location Privacy Protection Act of 2012); draft legislation not formally introduced as of 6-30-2013; to address voluntary location tracking of electronic communications devices. General lobbying with regard to alternative litigation funding. General lobbying with regard to notice pleading. in civil actions. General lobbying with regard to limitations on the ability to bring class actions involving the securities industry. S. 954 (Agriculture Reform, Food, and Jobs Act of 2013); specific interest in proposed amendment (not formally offered) relating to attorneys fees. S.1009 (Chemical Safety Improvement Act of 2013); to improve the safety of consumers and modernize the Toxic Substances Control Act. H.R. 1773 (AG Act); specific interest in amendments (offered in Committee) relating to requirement that farm employees mediate/arbitration all claims. S. 394 (Metal Theft Prevention Act of 2013); specific interest in proposed amendment (not formally offered) relating to transparency for outside counsel retained by State Attorneys General. General lobbying with regard to the Monsanto Protection Act; to limit judicial review of genetically modified seeds.

S.1718/H.R.1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses.

S.1718/H.R.1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses. H.R.5284 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act); to amend section 1862 of the Social Security Act with respect to the application of Medicare secondary payer rules to workers' compensation settlement agreements and Medicare set-asides under such agreements.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 3-31-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying on the issue of enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. Lobbying with regard to corporate accountability for exposure to asbestos and other toxic substances; and with regard to asbestos bankruptcy trusts.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers. H.R. 6584 (Verifying Authority and Legality In Drug Compounding Act of 2012), to amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products; specific interest in preservation of state-based causes of action. General lobbying with regard to the regulation of compoudning pharmacies and preservation of state-based causes of action. S.1223 (Location Privacy Protection Act of 2012); to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions and impact of Class Action Fairness Act. S.3317/H.R.5978 (Equal Employment Opportunity Restoration Act); to restore the effective use of group actions for claims arising under title VII of the Civil Rights Act of 1964, title I of the Americans with Disabilities Act of 1990, title V of the Rehabilitation Act of 1973, section 1977 of the Revised Statutes, and the Genetic Information Nondiscrimination Act of 2008. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Andrew Hurwitz and Paul Watford.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 3-31-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. Lobbying with regard to the ability of State Attorneys General to enforce federal law and hire outside counsel to enforce federal law. H.R. 3041, the Federal Consent Decree Fairness Act, to limit the duration of Federal consent decrees to which State and local governments are a party. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nomination of Miranda Du Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions and impact of Class Action Fairness Act. S.3317/H.R.5978 (Equal Employment Opportunity Restoration Act); to restore the effective use of group actions for claims arising under title VII of the Civil Rights Act of 1964, title I of the Americans with Disabilities Act of 1990, title V of the Rehabilitation Act of 1973, section 1977 of the Revised Statutes, and the Genetic Information Nondiscrimination Act of 2008. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Andrew Hurwitz and Paul Watford.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the destruction of electronic litigation data and original documents used in civil cases involving housing disputes. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. H.R.4078 (Red Tape Reduction and Small Business Job Creation Act ); specific interest in Lummis amendment (H.AMDT.1468) requiring the tracking and reporting of all payments issued pursuant to the Equal Access to Justice Act. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Robert Bacharach and Paul Grimm. S.3523 (Innovative Design Protection Act of 2012); specific interest in Lee amendment to require the losing party to pay the winning party's legal fees in certain litigation.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of Brian Davis, Caitlin Joan Halligan, Patty Shwartz, William J. Kayatta, Jr. and Jill A. Pryor. S.3525 (Sportsmen's Act of 2012); specific interest in S.Amdt. 2871 (Barrasso) (filed but not offered) to require the disclosure of all payments made under the Equal Access to Justice Act.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 3-31-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. Lobbying with regard to the ability of State Attorneys General to enforce federal law and hire outside counsel to enforce federal law. H.R. 3041, the Federal Consent Decree Fairness Act, to limit the duration of Federal consent decrees to which State and local governments are a party. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nomination of Miranda Du Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.5652 (Sequester Replacement Reconciliation Act); specific interest in provisions setting conditions for lawsuits arising from health care liabiltiy claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce; lobbying on H.R. 5 generally; also specific interest in: H.AMDT.989, to address the crisis in access to emergency care by extending liability coverage to on-call and emergency room physicians under the Public Health Service Act; H.AMDT 990, to restore the application of antitrust laws to the business of health insurance by amending the McCarran-Ferguson Act; H.AMDT 991, to grant limited civil liability protection to health professionals that volunteer at federally declared disaster sites; and H.AMDT 988, to delay the date of enactment until the Secretary of Health and Human Services submits to Congress a report on the potential effect of this title on health care premiums. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act) to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives H.R. 4022 (Structured Settlement Claimaints Rights Act); to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.5652 (Sequester Replacement Reconciliation Act); specific interest in provisions setting conditions for lawsuits arising from health care liabiltiy claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R. 6684 (Spending Reduction Act of 2012); specific interest in proivions relating to medical malpractice reform. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 3-31-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying on the issue of enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. Lobbying with regard to corporate accountability for exposure to asbestos and other toxic substances; and with regard to asbestos bankruptcy trusts.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers. H.R. 6584 (Verifying Authority and Legality In Drug Compounding Act of 2012), to amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products; specific interest in preservation of state-based causes of action. General lobbying with regard to the regulation of compoudning pharmacies and preservation of state-based causes of action. S.1223 (Location Privacy Protection Act of 2012); to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions and impact of Class Action Fairness Act. S.3317/H.R.5978 (Equal Employment Opportunity Restoration Act); to restore the effective use of group actions for claims arising under title VII of the Civil Rights Act of 1964, title I of the Americans with Disabilities Act of 1990, title V of the Rehabilitation Act of 1973, section 1977 of the Revised Statutes, and the Genetic Information Nondiscrimination Act of 2008. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Andrew Hurwitz and Paul Watford.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 3-31-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. Lobbying with regard to the ability of State Attorneys General to enforce federal law and hire outside counsel to enforce federal law. H.R. 3041, the Federal Consent Decree Fairness Act, to limit the duration of Federal consent decrees to which State and local governments are a party. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nomination of Miranda Du Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce; lobbying on H.R. 5 generally; also specific interest in: H.AMDT.989, to address the crisis in access to emergency care by extending liability coverage to on-call and emergency room physicians under the Public Health Service Act; H.AMDT 990, to restore the application of antitrust laws to the business of health insurance by amending the McCarran-Ferguson Act; H.AMDT 991, to grant limited civil liability protection to health professionals that volunteer at federally declared disaster sites; and H.AMDT 988, to delay the date of enactment until the Secretary of Health and Human Services submits to Congress a report on the potential effect of this title on health care premiums. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act) to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives H.R. 4022 (Structured Settlement Claimaints Rights Act); to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce; lobbying on H.R. 5 generally; also specific interest in: H.AMDT.989, to address the crisis in access to emergency care by extending liability coverage to on-call and emergency room physicians under the Public Health Service Act; H.AMDT 990, to restore the application of antitrust laws to the business of health insurance by amending the McCarran-Ferguson Act; H.AMDT 991, to grant limited civil liability protection to health professionals that volunteer at federally declared disaster sites; and H.AMDT 988, to delay the date of enactment until the Secretary of Health and Human Services submits to Congress a report on the potential effect of this title on health care premiums. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act) to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives H.R. 4022 (Structured Settlement Claimaints Rights Act); to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.5652 (Sequester Replacement Reconciliation Act); specific interest in provisions setting conditions for lawsuits arising from health care liabiltiy claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers. H.R. 6584 (Verifying Authority and Legality In Drug Compounding Act of 2012), to amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products; specific interest in preservation of state-based causes of action. General lobbying with regard to the regulation of compoudning pharmacies and preservation of state-based causes of action. S.1223 (Location Privacy Protection Act of 2012); to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers. H.R. 6584 (Verifying Authority and Legality In Drug Compounding Act of 2012), to amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products; specific interest in preservation of state-based causes of action. General lobbying with regard to the regulation of compoudning pharmacies and preservation of state-based causes of action. S.1223 (Location Privacy Protection Act of 2012); to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

S.1718/H.R.1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses. H.R.5284 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act); to amend section 1862 of the Social Security Act with respect to the application of Medicare secondary payer rules to workers' compensation settlement agreements and Medicare set-asides under such agreements.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.5652 (Sequester Replacement Reconciliation Act); specific interest in provisions setting conditions for lawsuits arising from health care liabiltiy claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 3-31-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. Lobbying with regard to the ability of State Attorneys General to enforce federal law and hire outside counsel to enforce federal law. H.R. 3041, the Federal Consent Decree Fairness Act, to limit the duration of Federal consent decrees to which State and local governments are a party. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nomination of Miranda Du Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions and impact of Class Action Fairness Act. S.3317/H.R.5978 (Equal Employment Opportunity Restoration Act); to restore the effective use of group actions for claims arising under title VII of the Civil Rights Act of 1964, title I of the Americans with Disabilities Act of 1990, title V of the Rehabilitation Act of 1973, section 1977 of the Revised Statutes, and the Genetic Information Nondiscrimination Act of 2008. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Andrew Hurwitz and Paul Watford.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the destruction of electronic litigation data and original documents used in civil cases involving housing disputes. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. H.R.4078 (Red Tape Reduction and Small Business Job Creation Act ); specific interest in Lummis amendment (H.AMDT.1468) requiring the tracking and reporting of all payments issued pursuant to the Equal Access to Justice Act. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Robert Bacharach and Paul Grimm. S.3523 (Innovative Design Protection Act of 2012); specific interest in Lee amendment to require the losing party to pay the winning party's legal fees in certain litigation.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of Brian Davis, Caitlin Joan Halligan, Patty Shwartz, William J. Kayatta, Jr. and Jill A. Pryor. S.3525 (Sportsmen's Act of 2012); specific interest in S.Amdt. 2871 (Barrasso) (filed but not offered) to require the disclosure of all payments made under the Equal Access to Justice Act.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions and impact of Class Action Fairness Act. S.3317/H.R.5978 (Equal Employment Opportunity Restoration Act); to restore the effective use of group actions for claims arising under title VII of the Civil Rights Act of 1964, title I of the Americans with Disabilities Act of 1990, title V of the Rehabilitation Act of 1973, section 1977 of the Revised Statutes, and the Genetic Information Nondiscrimination Act of 2008. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Andrew Hurwitz and Paul Watford.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers. H.R. 6584 (Verifying Authority and Legality In Drug Compounding Act of 2012), to amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products; specific interest in preservation of state-based causes of action. General lobbying with regard to the regulation of compoudning pharmacies and preservation of state-based causes of action. S.1223 (Location Privacy Protection Act of 2012); to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers. H.R. 6584 (Verifying Authority and Legality In Drug Compounding Act of 2012), to amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products; specific interest in preservation of state-based causes of action. General lobbying with regard to the regulation of compoudning pharmacies and preservation of state-based causes of action. S.1223 (Location Privacy Protection Act of 2012); to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers. H.R. 6584 (Verifying Authority and Legality In Drug Compounding Act of 2012), to amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products; specific interest in preservation of state-based causes of action. General lobbying with regard to the regulation of compoudning pharmacies and preservation of state-based causes of action. S.1223 (Location Privacy Protection Act of 2012); to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R. 6684 (Spending Reduction Act of 2012); specific interest in proivions relating to medical malpractice reform. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the destruction of electronic litigation data and original documents used in civil cases involving housing disputes. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. H.R.4078 (Red Tape Reduction and Small Business Job Creation Act ); specific interest in Lummis amendment (H.AMDT.1468) requiring the tracking and reporting of all payments issued pursuant to the Equal Access to Justice Act. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Robert Bacharach and Paul Grimm. S.3523 (Innovative Design Protection Act of 2012); specific interest in Lee amendment to require the losing party to pay the winning party's legal fees in certain litigation.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 3-31-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. Lobbying with regard to the ability of State Attorneys General to enforce federal law and hire outside counsel to enforce federal law. H.R. 3041, the Federal Consent Decree Fairness Act, to limit the duration of Federal consent decrees to which State and local governments are a party. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nomination of Miranda Du Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions and impact of Class Action Fairness Act. S.3317/H.R.5978 (Equal Employment Opportunity Restoration Act); to restore the effective use of group actions for claims arising under title VII of the Civil Rights Act of 1964, title I of the Americans with Disabilities Act of 1990, title V of the Rehabilitation Act of 1973, section 1977 of the Revised Statutes, and the Genetic Information Nondiscrimination Act of 2008. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Andrew Hurwitz and Paul Watford.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of Brian Davis, Caitlin Joan Halligan, Patty Shwartz, William J. Kayatta, Jr. and Jill A. Pryor. S.3525 (Sportsmen's Act of 2012); specific interest in S.Amdt. 2871 (Barrasso) (filed but not offered) to require the disclosure of all payments made under the Equal Access to Justice Act.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions and impact of Class Action Fairness Act. S.3317/H.R.5978 (Equal Employment Opportunity Restoration Act); to restore the effective use of group actions for claims arising under title VII of the Civil Rights Act of 1964, title I of the Americans with Disabilities Act of 1990, title V of the Rehabilitation Act of 1973, section 1977 of the Revised Statutes, and the Genetic Information Nondiscrimination Act of 2008. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Andrew Hurwitz and Paul Watford.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence and Federal Rules of Civil Procedure. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 3-31-2012; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. Lobbying with regard to the ability of State Attorneys General to enforce federal law and hire outside counsel to enforce federal law. H.R. 3041, the Federal Consent Decree Fairness Act, to limit the duration of Federal consent decrees to which State and local governments are a party. H.R. 3862, the Sunshine for Regulatory Decrees and Settlements Act, to impose certain limitations on consent decrees and settlement agreements by agencies that require the agencies to take regulatory action in accordance with the terms thereof. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nomination of Miranda Du Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce; lobbying on H.R. 5 generally; also specific interest in: H.AMDT.989, to address the crisis in access to emergency care by extending liability coverage to on-call and emergency room physicians under the Public Health Service Act; H.AMDT 990, to restore the application of antitrust laws to the business of health insurance by amending the McCarran-Ferguson Act; H.AMDT 991, to grant limited civil liability protection to health professionals that volunteer at federally declared disaster sites; and H.AMDT 988, to delay the date of enactment until the Secretary of Health and Human Services submits to Congress a report on the potential effect of this title on health care premiums. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act) to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives H.R. 4022 (Structured Settlement Claimaints Rights Act); to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments.

S.1718/H.R.1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses.

H.R. 1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to the efficiency of compensating patients suffering vaccine-related injuries under the National Vaccine Injury Compensation Program. Lobbying with regard to Medicare set-asides for claimant related medical expenses.

H.R. 1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. H.R 1517 (Holly Lynn James Act); specific interest in the legal remedies available to active duty and retired military personnel who are victims of sexual assault and harrassment. Lobbying with regard to relator fees and disclosure requirements in whistleblower actions under the False Claims Act. Lobbying with regard to certification of class actions. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; and lobbying with specific interest in the nomination of George Beck to the Middle District of Alabama. Lobbying with regard to the rulemaking process as required under the James Zadroga 9/11 Health and Compensation Act.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 12-31-2011; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying on the issue of enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to corporate accountability for exposure to asbestos and other toxic substances; and with regard to asbestos bankruptcy trusts.

H.R.1873/S. 987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 09-30-2011; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. H.R.2219 (Department of Defense Appropriations Act, 2012); specific interest in the enforcability of mandatory pre-dispute arbitration provisions in the employment contracts of defense contractors. General lobbying on the issue of enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts. (The Foreign Manufacturers Legal Accountability Act), draft legislation not formally introduced as of 09-30-2011; to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving drug manufacturers. Lobbying with regard to corporate accountability for exposure to asbestos and other toxic substances; and with regard to asbestos bankruptcy trusts.

H.R. 1873/S. 987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 06-30-2011; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. H.R.2219 (Department of Defense Appropriations Act, 2012); specific interest to the enforcability of mandatory pre-dispute arbitration provisions in the employment contracts of defense contractors. General lobbying on the issue of enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts. (The Foreign Manufacturers Legal Accountability Act), draft legislation not formally introduced as of 06-30-2011; to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving drug manufacturers. Lobbying with regard to corporate accountability for exposure to asbestos and other toxic substances; and with regard to asbestos bankruptcy trusts.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 1606/H.R. 3010 (Regulatory Accountability Act); to provide new requirements under that Administrative Procedure Act for major rules. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence. Lobbying with regard to certification of class actions. S. 1061/H.R. 1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 9-30-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. S.299/ H.R.10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S.1606/H.R.3010 (Regulatory Accountability Act); to provide new requirements under the Administrative Procedure Act for major rules. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 12-31-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R.3289 (Whistleblower Protection Enhancement Act of 2011); specific interest in Rep. Braley amendment to guarantee right to trial by jury. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. S.299/ H.R.10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S.1606/H.R.3010 (Regulatory Accountability Act); to provide new requirements under the Administrative Procedure Act for major rules. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 12-31-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R.3289 (Whistleblower Protection Enhancement Act of 2011); specific interest in Rep. Braley amendment to guarantee right to trial by jury. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 1606/H.R. 3010 (Regulatory Accountability Act); to provide new requirements under that Administrative Procedure Act for major rules. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence. Lobbying with regard to certification of class actions. S. 1061/H.R. 1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 9-30-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S.1099/H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. Lobbying with regard to medical malpractice reform proposals generally. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. H.R.3239 (Safeguarding Access For Every Medicare Patient Act); to provide certain legal safe harbors to Medicare and Medicaid providers who participate in the Electronic Health Record meaningful use program or otherwise demonstrate use of certified health information technology. H.R.3586 (Good Samaritan Health Professionals Act); to limit the liability of health care professionals who volunteer to provide health care services in response to a disaster. (Renewable Fuels Marketing Act), draft legislation not formally introduced as of 12-31-2011; specific interest in provisions granting immunity from civil liabilty relating to use of ethanol mixed fuels. (Structured Settlement Claimants Rights Act), draft legislation not formally introduced as of 12-31-2011; to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments. H.R.2112 (Consolidated and Further Continuing Appropriations Act); specific interest in provision granting schools immunity from civil liability for donating excess food.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. S.299/ H.R.10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S.1606/H.R.3010 (Regulatory Accountability Act); to provide new requirements under the Administrative Procedure Act for major rules. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 12-31-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R.3289 (Whistleblower Protection Enhancement Act of 2011); specific interest in Rep. Braley amendment to guarantee right to trial by jury. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S.1099/H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. Lobbying with regard to medical malpractice reform proposals generally. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. H.R.3239 (Safeguarding Access For Every Medicare Patient Act); to provide certain legal safe harbors to Medicare and Medicaid providers who participate in the Electronic Health Record meaningful use program or otherwise demonstrate use of certified health information technology. H.R.3586 (Good Samaritan Health Professionals Act); to limit the liability of health care professionals who volunteer to provide health care services in response to a disaster. (Renewable Fuels Marketing Act), draft legislation not formally introduced as of 12-31-2011; specific interest in provisions granting immunity from civil liabilty relating to use of ethanol mixed fuels. (Structured Settlement Claimants Rights Act), draft legislation not formally introduced as of 12-31-2011; to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments. H.R.2112 (Consolidated and Further Continuing Appropriations Act); specific interest in provision granting schools immunity from civil liability for donating excess food.

S.1099/H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. Lobbying with regard to medical malpractice reform proposals generally. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. H.R.3239 (Safeguarding Access For Every Medicare Patient Act); to provide certain legal safe harbors to Medicare and Medicaid providers who participate in the Electronic Health Record meaningful use program or otherwise demonstrate use of certified health information technology. H.R.3586 (Good Samaritan Health Professionals Act); to limit the liability of health care professionals who volunteer to provide health care services in response to a disaster. (Renewable Fuels Marketing Act), draft legislation not formally introduced as of 12-31-2011; specific interest in provisions granting immunity from civil liabilty relating to use of ethanol mixed fuels. (Structured Settlement Claimants Rights Act), draft legislation not formally introduced as of 12-31-2011; to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments. H.R.2112 (Consolidated and Further Continuing Appropriations Act); specific interest in provision granting schools immunity from civil liability for donating excess food.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 12-31-2011; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying on the issue of enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to corporate accountability for exposure to asbestos and other toxic substances; and with regard to asbestos bankruptcy trusts.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. H.R 1517 (Holly Lynn James Act); specific interest in the legal remedies available to active duty and retired military personnel who are victims of sexual assault and harrassment. Lobbying with regard to relator fees and disclosure requirements in whistleblower actions under the False Claims Act. Lobbying with regard to certification of class actions. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; and lobbying with specific interest in the nomination of George Beck to the Middle District of Alabama. Lobbying with regard to the rulemaking process as required under the James Zadroga 9/11 Health and Compensation Act.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 1606/H.R. 3010 (Regulatory Accountability Act); to provide new requirements under that Administrative Procedure Act for major rules. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence. Lobbying with regard to certification of class actions. S. 1061/H.R. 1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 9-30-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in Federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the Federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. H.R. 1 (Full-Year Continuing Appropriations Act); specific interest in House Amdt. 85 to defund the Equal Access to Justice program, and House Amdt.159 to defund the the Consumer Product Safety Commission Product Safety Database. H.R. 887(no short title); to direct the Secretary of the Interior to submit a report on Indian land fractionation, and for other purposes, specific interest in the modification of attorney's fees. (Holly Lynn James Act), draft legislation not formally introduced as of 03-31-2011; specific interest in the legal remedies available to active duty and retired military personnel who are victims of sexual assault and harrassment. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. S.299/ H.R.10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S.1606/H.R.3010 (Regulatory Accountability Act); to provide new requirements under the Administrative Procedure Act for major rules. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 12-31-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R.3289 (Whistleblower Protection Enhancement Act of 2011); specific interest in Rep. Braley amendment to guarantee right to trial by jury. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. H.R 1517 (Holly Lynn James Act); specific interest in the legal remedies available to active duty and retired military personnel who are victims of sexual assault and harrassment. Lobbying with regard to relator fees and disclosure requirements in whistleblower actions under the False Claims Act. Lobbying with regard to certification of class actions. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; and lobbying with specific interest in the nomination of George Beck to the Middle District of Alabama. Lobbying with regard to the rulemaking process as required under the James Zadroga 9/11 Health and Compensation Act.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 1606/H.R. 3010 (Regulatory Accountability Act); to provide new requirements under that Administrative Procedure Act for major rules. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence. Lobbying with regard to certification of class actions. S. 1061/H.R. 1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 9-30-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in Federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the Federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. H.R. 1 (Full-Year Continuing Appropriations Act); specific interest in House Amdt. 85 to defund the Equal Access to Justice program, and House Amdt.159 to defund the the Consumer Product Safety Commission Product Safety Database. H.R. 887(no short title); to direct the Secretary of the Interior to submit a report on Indian land fractionation, and for other purposes, specific interest in the modification of attorney's fees. (Holly Lynn James Act), draft legislation not formally introduced as of 03-31-2011; specific interest in the legal remedies available to active duty and retired military personnel who are victims of sexual assault and harrassment. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in Federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the Federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. H.R. 1 (Full-Year Continuing Appropriations Act); specific interest in House Amdt. 85 to defund the Equal Access to Justice program, and House Amdt.159 to defund the the Consumer Product Safety Commission Product Safety Database. H.R. 887(no short title); to direct the Secretary of the Interior to submit a report on Indian land fractionation, and for other purposes, specific interest in the modification of attorney's fees. (Holly Lynn James Act), draft legislation not formally introduced as of 03-31-2011; specific interest in the legal remedies available to active duty and retired military personnel who are victims of sexual assault and harrassment. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S. 218/H.R. 5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. Lobbying with regard to medical malpractice reform proposals generally. H.R.963 (See Something, Say Something Act of 2011); to grant immunity from civil liability to persons who report suspicious activity indicating that an individual may be engaging in terrorism.

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. S.299/ H.R.10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S.1606/H.R.3010 (Regulatory Accountability Act); to provide new requirements under the Administrative Procedure Act for major rules. Lobbying with regard to the Judicial Conference of the United States' proposed amendments to the Federal Rules of Evidence. Lobbying with regard to certification of class actions. S.1061/H.R.1996 (Government Litigation Savings Act); to restrict the the award of fees and other expenses in cases brought against agencies of the United States under the Equal Access to Justice Act, and to require and make publically available certain data relating to awards under the Equal Access to Justice Act. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 12-31-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to preservation of documents for e-discovery and the use of sanctions to enforce compliance with discovery orders for electronic documents. H.R.3289 (Whistleblower Protection Enhancement Act of 2011); specific interest in Rep. Braley amendment to guarantee right to trial by jury. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; not specific to any nominated candidate.

S. 623/H.R. 592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R. 966/S. 533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the restoration of notice pleading in federal courts. H.R. 394 (Federal Courts Jurisdiction and Venue Clarification Act); to clarify the jurisdiction of the federal courts, and for other purposes. S. 299/ H.R. 10 (Regulations From the Executive in Need of Scrutiny Act of 2011); to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. H.R 1517 (Holly Lynn James Act); specific interest in the legal remedies available to active duty and retired military personnel who are victims of sexual assault and harrassment. Lobbying with regard to relator fees and disclosure requirements in whistleblower actions under the False Claims Act. Lobbying with regard to certification of class actions. (Protecting the Expression and Transmission of Ideas and Thoughts in Our Nation Act), draft bill not formally introduced as of 6-30-2011; to establish special motions and procedures to quickly dispose of strategic lawsuits against public participation. Lobbying with regard to federal judicial selection generally; not specific to any nominated candidate. Lobbying with regard to US attorney selection generally; and lobbying with specific interest in the nomination of George Beck to the Middle District of Alabama. Lobbying with regard to the rulemaking process as required under the James Zadroga 9/11 Health and Compensation Act.